Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
Authors:
- Metin OzkanMOMetin Ozkan
- Ozgur GunebakmazOGOzgur Gunebakmaz
- Hasan AkkayaHAHasan Akkaya
- Esma G. KayaEKEsma G. Kaya
- Mahmut AkpekMAMahmut Akpek
- Nihat KalayNKNihat Kalay
- Mustafa DikilitasMDMustafa Dikilitas
- Mikail YarliogluesMYMikail Yarlioglues
- Halit KaracaHKHalit Karaca
- Veli BerkVBVeli Berk
- Idris ArdicIAIdris Ardic
- 1 September 2013
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 167 (5) , 2306-2310
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- L-carnitine reduces doxorubicin-induced apoptosis through a prostacyclin-mediated pathway in neonatal rat cardiomyocytesInternational Journal of Cardiology, 2011
- CO and bilirubin inhibit doxorubicin-induced cardiac cell deathImmunopharmacology and Immunotoxicology, 2009
- Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heartEuropean Journal of Cancer, 2008
- The Endothelin Receptor Blocker Bosentan Inhibits Doxorubicin-Induced CardiomyopathyCancer Research, 2007
- Preventive Cardioprotection of Erythropoietin Against Doxorubicin-induced CardiomyopathyCardiovascular Drugs and Therapy, 2007
- Cardiotoxicity of cytotoxic drugsCancer Treatment Reviews, 2004
- Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Adriamycin-Induced Cardiomyopathy in HamstersThe Japanese Journal of Pharmacology, 2002
- Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in ratsLife Sciences, 1999
- Cardiomyocyte apoptosis and progression of heart failure to transplantationEuropean Journal of Clinical Investigation, 1999
- Cardiotoxicity of the Antiproliferative Compound FluorouracilDrugs, 1999